Microsoft: Fiscal Q4 Earnings Consensus Estimates

Microsoft (NASDAQ: MSFT) will be reporting their fiscal fourth quarter financials on July 27 after markets close. Analysts have a consensus $306.13 12-month price target on the company, via a total of 40 analysts, with 18 analysts having strong buy ratings. 20 analysts meanwhile have buy ratings and two have hold ratings. The street high sits at a $378 price target, and the lowest target sits at $256.70.

23 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 23 analysts is $44.243 billion; this number has been revised upwards from $41.9 billion at the start of the year. The highest revenue estimate is $44.869 billion, while the lowest is $43.629 billion.

Onto EBITDA estimates, there are currently only 5 analysts who have fourth-quarter EBITDA estimates. The mean is currently $20.747 billion, with this number having been revised up from $18.474 billion at the start of the year. Street high is $20.915 billion EBITDA estimate and the lowest is $20.229 billion.

Analysts estimate that quarterly earnings per share will come in at $1.92, with this number being revised upwards from $1.71 at the start of the year. Street high is $2.03 and the lowest estimate is $1.81 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Can Historic Silver Data Turn Into a New Mine? | Rob Macdonald – Equity Metals

Is This the Most Overlooked Critical Mineral? (+1000% Move) | Guy Bourassa – Scandium Canada

Is Gold Entering a New 15-Year Cycle? | Rod Husband

Recommended

Silver47 Launches 7,000-Meter Hughes Drill Program In Nevada

Advanced Gold Acquires Nevada Property With Historic Production At 1,611 g/t Silver

Related News

Cantor Releases Industry Report For Cannabis, Aphria Remains Top Pick

Recently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending...

Sunday, October 4, 2020, 01:57:00 PM

Tilray: Cantor Slashes Price Target To $7.40 Ahead Of Earnings

Tilray (TSX: TLRY) is expected to report its second fiscal quarter 2022 results on January...

Friday, January 7, 2022, 03:58:00 PM

HEXO: Canaccord Lowers Price Target Following Redecan Transaction Announcement

On May 28th, Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced yet another acquisition. The company...

Tuesday, June 1, 2021, 11:51:00 AM

Trulieve: Five Analysts Raise Price Targets Following Stellar Earnings

Trulieve Cannabis (CSE: TRUL) reported their second-quarter financial results this week, boasting a record U$120.8...

Friday, August 14, 2020, 11:43:41 AM

Well Health: Canaccord Slashes Price Target To $6

On May 11th, WELL Health Technologies Corp. (TSX: WELL) reported its first quarter financial results....

Wednesday, May 25, 2022, 04:11:00 PM